STING1 and neoplasm: Collectively, these data demonstrate the complementary contributions of both the EcN bacterial chassis and the production of the STING agonist CDA towards the generation of an efficacious and durable antitumor immune response in two distinct murine tumor models (B16F10 and A20) in two genetic backgrounds (C57BL/6 and BALB/c).